Wang Wen-Ru, Wang Xin-Hui, Yan Lei, Zeng Qin, Zhan Tian, Zhan Jing-Yi, Li Ji-Xin, Yu Ren-Huan
Xiyuan Hospital, China Academy of Chinese Medical Sciences Beijing 100091, China.
Zhongguo Zhong Yao Za Zhi. 2024 Aug;49(15):4044-4053. doi: 10.19540/j.cnki.cjcmm.20240412.708.
Diabetic kidney disease(DKD) is a prevalent and severe microvascular complication of type 2 diabetes mellitus(T2DM). Chronic microinflammation is an important factor exacerbating renal tissue damage in DKD individuals. Macrophages play a crucial role in immune-inflammatory responses, and they can transiently and reversibly polarize into the pro-inflammatory M1 phenotype and anti-inflammatory M2 phenotype based on microenvironmental differences. The imbalance in M1/M2 macrophage polarization can exacerbate DKD progression by fostering inflammatory cytokine aggregation in the glomeruli and renal interstitium. Therefore, restoring the balance of macrophage is a pivotal avenue to ameliorate the chronic microinflammation state in DKD. Macrophage polarization is a complex and dynamic process. Various information molecules and cytokines involved in the polarization process play important roles in regulating phenotypes during the progression of DKD. They are closely related to various mechanisms such as metabolism, inflammation, fibrosis, and mitochondrial autophagy in DKD. By coordinating the inflammatory responses through polarization, they play a key role in regulating inflammation in metabolic-related diseases. The complex network of pathways involved in macrophage polarization corresponds well with the multi-pathway, multi-target treatment model of traditional Chinese medicine(TCM). Active ingredients and formulas of TCM can intervene in DKD by regulating macrophage polarization. Studies on relieving renal inflammation, repairing renal tissues, and promoting renal function recovery through macrophage polarization modulation are not uncommon. Therefore, based on exis-ting evidence, this study reviews TCM in targeting M1/M2 macrophage polarization balance to improve DKD, aiming to explore the potential of macrophage polarization in regulating DKD, which is expected to provide evidence support for the clinical diagnosis and treatment of DKD with TCM as well as the exploration of its biological mechanisms.
糖尿病肾病(DKD)是2型糖尿病(T2DM)常见且严重的微血管并发症。慢性微炎症是加重DKD患者肾组织损伤的重要因素。巨噬细胞在免疫炎症反应中起关键作用,它们可根据微环境差异短暂且可逆地极化为促炎性M1表型和抗炎性M2表型。M1/M2巨噬细胞极化失衡可通过促进肾小球和肾间质中炎性细胞因子聚集而加剧DKD进展。因此,恢复巨噬细胞平衡是改善DKD慢性微炎症状态的关键途径。巨噬细胞极化是一个复杂且动态的过程。参与极化过程的各种信息分子和细胞因子在DKD进展过程中调节表型方面发挥重要作用。它们与DKD中的代谢、炎症、纤维化和线粒体自噬等多种机制密切相关。通过极化协调炎症反应,它们在调节代谢相关疾病的炎症中起关键作用。巨噬细胞极化所涉及的复杂信号通路网络与中医的多途径、多靶点治疗模式高度契合。中药活性成分和方剂可通过调节巨噬细胞极化干预DKD。通过调节巨噬细胞极化来减轻肾脏炎症、修复肾组织和促进肾功能恢复的研究并不少见。因此,基于现有证据,本研究综述了中医针对M1/M2巨噬细胞极化平衡改善DKD的研究,旨在探讨巨噬细胞极化在调节DKD中的潜力,有望为DKD的中医临床诊疗及其生物学机制探索提供证据支持。